Although the high expression of GPNMB in breast cancer tissues is reported as a poor prognostic indicator for recurrence21 and an antibody-drug conjugate targeting GPNMB has been postulated25, many researchers are trying to elucidate the role of Gpnmb in immune responses. This evidence concerns the gene GPNMB and breast carcinoma.